Bruker Energy & Supercon Technologies Hires Franco Moriconi as Vice President of Product Development and Engineering for Power Grids

FREMONT, Calif. -- Bruker Energy & Supercon Technologies, Inc. (BEST), a leading developer and manufacturer of advanced superconducting materials and devices, announced today the appointment of Franco Moriconi as Vice President of Product Development and Engineering for Power Grids. Mr. Moriconi is now based at BEST's California site in Fremont, where he will be responsible [...]

Linguamatics and ChemAxon Announce Project to Enhance Text Mining in Chemistry

CAMBRIDGE, England & BUDAPEST, Hungary & BOSTON--Linguamatics and ChemAxon are pleased to announce that they are partnering in a new, path-breaking project funded by EUREKA’s Eurostars Programme. The project is code-named “ChiKEL”, which means Chemically Informed Knowledge Extraction from Literature. ChiKEL will provide the first interactive text mining system designed for chemistry, integrating advanced chemical [...]

DNA2.0 Integrates Synthetic Biology Open Language (SBOL) Into Gene Designer

Menlo Park, CA - DNA2.0 the leading provider of bioengineering solutions, today announced the integration of the Synthetic Biology Open Language (SBOL) into the company’s groundbreaking gene design and assembly tool, Gene Designer. SBOL is a synthetic biology standard exchange format that allows scientists to share, store, explore and publish genetic elements created through computer [...]

Danaher Reaffirms 2011 Guidance and Initiates 2012 Outlook

WASHINGTON -- Ahead of an institutional investor and analyst meeting to be held in New York, Danaher Corporation (NYSE: DHR) reaffirmed the Company's fourth quarter 2011 adjusted diluted earnings per share guidance of $0.75 - $0.80. The fourth quarter guidance includes $0.74 - $0.79 of earnings per share from continuing operations and $0.01 of earnings [...]

METTLER TOLEDO FlowIR Gives Ley Team Window on Reactions

The METTLER TOLEDO FlowIR flow chemistry monitoring system is providing valuable particle characterization knowledge for synthesis projects performed by the Ley Group at the Department of Chemistry, University of Cambridge. FlowIR is a dedicated Fourier Transform Infrared Spectroscopy (FTIR) instrument for real-time continuous flow chemistry monitoring. Fast, real-time information on reaction progress has allowed quicker [...]

Claremont BioSolutions and Funakoshi Announce Distribution Agreement for Japan

Claremont BioSolutions announces distributor in Japan to expand sales and marketing efforts worldwide. (PRWEB) December 14, 2011 Claremont BioSolutions, LLC announced today that it has reached an agreement with Funakoshi for the distribution of its products for sample preparation, DNA isolation, and protein purification in Japan. The agreement reflects ClaremontBio’s expansion of its marketing efforts [...]

Carl Zeiss: Revenue Tops Four Billion Euro Mark for Very First Time

Stuttgart - Carl Zeiss ended fiscal year 2010/11 (reporting date: 30 September 2011) with a clear increase in revenue and earnings over the prior year: with a total of EUR 4.237b, revenue topped the four billion euro mark for the very first time (prior year: EUR 2.981b). Earnings (EbIT) totaled EUR 607m (prior year: EUR [...]

Biohit Oyj and Sartorius Lab Holding GmbH complete sale of liquid handling business, Biohit Oyj revises risk outlook

The prerequisites for the completion of the sale of Biohit Oyj's liquid handling business to Sartorius Lab Holding GmbH have been met; the companies completed the sale on 14 December 2011. Upon the sale's completion, Biohit's liquid handling business transferred to Sartorius. The parties signed the sales contract on the sale of the liquid handling [...]

GnuBIO Begins Beta System Builds and Strengthens Supplier Relationships

CAMBRIDGE, Mass.--GnuBIO, Inc. (GnuBIO), www.gnubio.com a pioneer in the Desktop DNA sequencing market, announced today that it has initiated the build of its beta system. Using innovative approaches, the company has enhanced many technical capabilities found only in its droplet-based DNA sequencing system – including advances in molecular biology, real time informatics and optics - [...]

GE Healthcare and M+W Group form strategic alliance in vaccines, insulin and biopharmaceuticals

Chalfont St Giles, UK and Stuttgart, Germany – GE Healthcare, the healthcare business of GE (NYSE: GE) and M+W Group, a leading global engineering, construction and project management company, announced today that the companies have formed a strategic alliance aimed at overcoming the lack of key biopharmaceuticals, especially in emerging nations. The alliance, which will [...]

Access IBO on Knowledge Center